Sun Pharmaceutical Industries Ltd.

The Revenue for the quarter ended  December 2022 of Rs. 46457.50 millions grew by 23.21 % from Rs. 37706.60 millions.Net profit declined -5.57% to Rs. 4867.30 millions from Rs. 5154.30 millions.Operating profit for the quarter ended December 2022 rose to 10674.10 millions as compared to 9616.20 millions of corresponding quarter ended December 2021.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202212	202112	% Var	202212	202112	% Var	202203	202103	% Var
Sales	46457.50	37706.60	23.21	148639.20	115791.00	28.37	155859.80	141160.50	10.41
Other Income	746.30	3132.50	-76.18	2925.50	8092.10	-63.85	11968.80	1920.70	523.15
PBIDT	10674.10	9616.20	11.00	42709.40	25651.90	66.50	38654.40	24490.80	57.83
Interest	1308.90	854.70	53.14	3107.30	2969.10	4.65	3881.00	2675.20	45.07
PBDT	9365.20	8761.50	6.89	39602.10	21027.10	88.34	16568.10	20920.00	-20.80
Depreciation	4304.40	3552.40	21.17	11888.90	9958.10	19.39	13499.50	12364.30	9.18
PBT	5060.80	5209.10	-2.85	27713.20	11069.00	150.37	3068.60	8555.70	-64.13
TAX	193.50	54.80	253.10	597.80	-793.20	-175.37	4068.50	131.70	2989.22
Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
PAT	4867.30	5154.30	-5.57	27115.40	11862.20	128.59	-999.90	8424.00	-111.87
Equity	2399.30	2399.30	0.00	2399.30	2399.30	0.00	2399.30	2399.30	0.00
PBIDTM(%)	22.98	25.50	-9.91	28.73	22.15	29.70	24.80	17.35	42.95